962 related articles for article (PubMed ID: 18684674)
1. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.
Wu P; Wu J; Liu S; Han X; Lu J; Shi Y; Wang J; Lu L; Cao X
Clin Immunol; 2008 Oct; 129(1):40-8. PubMed ID: 18684674
[TBL] [Abstract][Full Text] [Related]
2. Negative regulation of TLR9-mediated IFN-alpha induction by a small-molecule, synthetic TLR7 ligand.
Marshall JD; Heeke DS; Gesner ML; Livingston B; Van Nest G
J Leukoc Biol; 2007 Sep; 82(3):497-508. PubMed ID: 17565046
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 inhibits IFN-alpha secretion and Th1 costimulation by human plasmacytoid dendritic cells via E-prostanoid 2 and E-prostanoid 4 receptor engagement.
Fabricius D; Neubauer M; Mandel B; Schütz C; Viardot A; Vollmer A; Jahrsdörfer B; Debatin KM
J Immunol; 2010 Jan; 184(2):677-84. PubMed ID: 20018632
[TBL] [Abstract][Full Text] [Related]
4. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus.
Blomberg S; Eloranta ML; Magnusson M; Alm GV; Rönnblom L
Arthritis Rheum; 2003 Sep; 48(9):2524-32. PubMed ID: 13130472
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 9 suppression in plasmacytoid dendritic cells after IgE-dependent activation is mediated by autocrine TNF-alpha.
Schroeder JT; Chichester KL; Bieneman AP
J Allergy Clin Immunol; 2008 Feb; 121(2):486-91. PubMed ID: 18036648
[TBL] [Abstract][Full Text] [Related]
6. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus.
Barrat FJ; Meeker T; Gregorio J; Chan JH; Uematsu S; Akira S; Chang B; Duramad O; Coffman RL
J Exp Med; 2005 Oct; 202(8):1131-9. PubMed ID: 16230478
[TBL] [Abstract][Full Text] [Related]
7. Blockade of TLR9 agonist-induced type I interferons promotes inflammatory cytokine IFN-gamma and IL-17 secretion by activated human PBMC.
Meyers JA; Mangini AJ; Nagai T; Roff CF; Sehy D; van Seventer GA; van Seventer JM
Cytokine; 2006 Sep; 35(5-6):235-46. PubMed ID: 17052915
[TBL] [Abstract][Full Text] [Related]
8. Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation.
Guiducci C; Ott G; Chan JH; Damon E; Calacsan C; Matray T; Lee KD; Coffman RL; Barrat FJ
J Exp Med; 2006 Aug; 203(8):1999-2008. PubMed ID: 16864658
[TBL] [Abstract][Full Text] [Related]
9. BDCA-2 signaling inhibits TLR-9-agonist-induced plasmacytoid dendritic cell activation and antigen presentation.
Jähn PS; Zänker KS; Schmitz J; Dzionek A
Cell Immunol; 2010; 265(1):15-22. PubMed ID: 20673884
[TBL] [Abstract][Full Text] [Related]
10. Plasmacytoid dendritic cells activate allergen-specific TH2 memory cells: modulation by CpG oligodeoxynucleotides.
Farkas L; Kvale EO; Johansen FE; Jahnsen FL; Lund-Johansen F
J Allergy Clin Immunol; 2004 Aug; 114(2):436-43. PubMed ID: 15316529
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 gp120 inhibits TLR9-mediated activation and IFN-{alpha} secretion in plasmacytoid dendritic cells.
Martinelli E; Cicala C; Van Ryk D; Goode DJ; Macleod K; Arthos J; Fauci AS
Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3396-401. PubMed ID: 17360657
[TBL] [Abstract][Full Text] [Related]
12. Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.
Sakata K; Nakayamada S; Miyazaki Y; Kubo S; Ishii A; Nakano K; Tanaka Y
Front Immunol; 2018; 9():1957. PubMed ID: 30210502
[No Abstract] [Full Text] [Related]
13. Effect of
Gardet A; Pellerin A; McCarl CA; Diwanji R; Wang W; Donaldson D; Franchimont N; Werth VP; Rabah D
Front Immunol; 2019; 10():275. PubMed ID: 30846987
[No Abstract] [Full Text] [Related]
14. Emerging roles of TLR7 and TLR9 in murine SLE.
Santiago-Raber ML; Baudino L; Izui S
J Autoimmun; 2009; 33(3-4):231-8. PubMed ID: 19846276
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.
Uematsu S; Sato S; Yamamoto M; Hirotani T; Kato H; Takeshita F; Matsuda M; Coban C; Ishii KJ; Kawai T; Takeuchi O; Akira S
J Exp Med; 2005 Mar; 201(6):915-23. PubMed ID: 15767370
[TBL] [Abstract][Full Text] [Related]
16. C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis.
Lood C; Gullstrand B; Truedsson L; Olin AI; Alm GV; Rönnblom L; Sturfelt G; Eloranta ML; Bengtsson AA
Arthritis Rheum; 2009 Oct; 60(10):3081-90. PubMed ID: 19790049
[TBL] [Abstract][Full Text] [Related]
17. Anti-BDCA2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc-dependent and Fc-independent mechanisms.
Pellerin A; Otero K; Czerkowicz JM; Kerns HM; Shapiro RI; Ranger AM; Otipoby KL; Taylor FR; Cameron TO; Viney JL; Rabah D
EMBO Mol Med; 2015 Apr; 7(4):464-76. PubMed ID: 25762615
[TBL] [Abstract][Full Text] [Related]
18. Bruton's tyrosine kinase regulates TLR9 but not TLR7 signaling in human plasmacytoid dendritic cells.
Wang J; Lau KY; Jung J; Ravindran P; Barrat FJ
Eur J Immunol; 2014 Apr; 44(4):1130-6. PubMed ID: 24375473
[TBL] [Abstract][Full Text] [Related]
19. Enhanced IFN-α production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus.
Murayama G; Furusawa N; Chiba A; Yamaji K; Tamura N; Miyake S
Arthritis Res Ther; 2017 Oct; 19(1):234. PubMed ID: 29052537
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor activation in the pathogenesis of systemic lupus erythematosus.
Means TK; Luster AD
Ann N Y Acad Sci; 2005 Dec; 1062():242-51. PubMed ID: 16461805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]